Brief: Praxis Precision Q3 EPS USD -2.75 Vs. IBES Estimate USD -1.99
06/11/2024 12:30
Nov 06 (Reuters) - Praxis Precision Q3 operating income USD -56.835 million vs. IBES estimate USD -40.5 million. * Q3 net income USD -51.91 million vs. IBES estimate USD -37.6 million * Q3 collaboration revenue USD 302 thousand * Q3 operating expenses USD 57.137 million
Recent news on Praxis Precision Medicines
See all newsUS RESEARCH ROUNDUP-Arxis, Cigna, Vylor
Brief: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Praxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary
Praxis Precision Q2 net loss widens on higher expenses
Brief: Praxis Precision Q2 EPS USD -2.87